Blood cancer patients may need higher antibiotic doses to beat superbugs
Knowledge-focused
Not yet recruiting
This study looks at whether the standard dose of the antibiotic ceftazidime-avibactam reaches high enough levels in the blood of people with blood cancers or those who have had a stem cell transplant. These patients are at high risk for severe infections from drug-resistant bacte…
Sponsor: Sizhou Feng • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC